BTG Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BTG Plc with three other
companies in this sector in the United Kingdom:
sales of £786.93 million [US$972.72 million]
Dechra Pharmaceuticals PLC
(£247.56 million [US$306.01 million]
of which 76%
was European Pharmaceuticals), and
Amarin Corporation PLC
(£96.76 million [US$119.60 million]
of which 100%
BTG Plc reported sales of £447.50 million (US$553.15 million)
March of 2016.
increase of 21.7%
versus 2015, when the company's sales were £367.80 million.
Sales at BTG Plc have increased during each of the previous five years
(and since 2011, sales have increased a total of 302%).
Sales of Interventional Medicine saw an increase
33.3% in 2016, from
£112.70 million to £150.20 million.